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ABSTRACT 
 
Comparison of Average Heart Rates Determined by Surface ECG and 24-Hour 
Ambulatory ECG (Holter) in Dogs with Spontaneous Atrial Fibrillation.  
(December 2010) 
Adriana Lucía Perea Lugo, B.S., Autonomous University of Zacatecas 
Chair of Advisory Committee: Dr. Theresa W. Fossum 
 
 The purpose of this study was to compare the heart rates of dogs presenting with 
spontaneous atrial fibrillation (AF) by a surface electrocardiogram (ECG) and a 24 hour 
ambulatory ECG (Holter recording) in order to determine if there was a difference 
between these two diagnostic tests. Seven dogs with clinically stable, spontaneous AF 
were evaluated with a 6 lead surface ECG (MAC 5000, GE® Milwaukee) and a Holter 
monitor (Monitor device: LifecardCE Delmar Reynolds Medical, Holter analysis:Aria 
Holter software). Statistical analyses, including t-tests and linear regression models, 
were performed using Stata® data-analysis and statistical software. 
 When heart rates (bpm) determined by both diagnostic testing methods were 
compared individually and among all of the dogs, no statistically significant differences 
were found.  Complete data for analysis were available in 4 of the 7 dogs.  This study 
demonstrates that despite the potential superiority of Holter monitoring relative to the 
surface ECG for the diagnosis of cardiac arrhythmias, average heart rates were not 
statistically different in these 4 dogs with controlled AF.  Therefore, the average HR 
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determined by surface ECG in the hospital may be as reliable as the average HR 
determined by Holter monitoring in dogs with well controlled spontaneous AF.   
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NOMENCLATURE 
 
AF Atrial fibrillation 
BE Bicavitary effusion 
 bpm Beats per minute 
CHF Congestive heart failure 
COPD  Chronic obstructive pulmonary disease 
DCM Dilated cardiomyopathy 
DVD Degenerative atrio-ventricular valve disease 
ECG Electrocardiogram 
Holter Ambulatory electrocardiogram 
HR Heart rate 
LD Lung disease 
MR Mitral regurgitation 
ODCM Occult dilated cardiomyopathy 
PH Pulmonary hypertension 
SAS Subvalvular aortic stenosis 
TVD Tricuspid valve dysplasia 
VPCs Ventricular premature complexes 
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1. INTRODUCTION 
 
 Atrial fibrillation is the most common supraventricular arrhythmia in dogs, 
representing 12–16% of all canine cardiac arrhythmias (1). Although it is not a common 
cause of death, it is considered to have one of the highest morbidities of all the 
arrhythmias (2). Its pathophysiology is highly complex and is commonly associated with 
a variety of cardiovascular diseases, in particular structural remodeling and ischemic 
changes (3) or any condition that causes atrial enlargement such as dilated 
cardiomyopathy, chronic obstructive pulmonary disease, mitral stenosis, mitral 
regurgitation, and chronic degenerative atrio-ventricular valve disease. It may also occur 
secondary to diseases of non-cardiogenic origin, for example in hypothyroidism or 
during anesthesia. In addition, AF may develop in the absence of any discernible heart 
disease, being termed lone or idiopathic AF. It more commonly affects large or giant-
breed dogs (Irish Wolfhound, Great Dane, Groendal, Mastiff, and Newfoundland) as 
opposed to small-breed dogs (4). This may occur because the establishment and 
maintenance of AF is believed to be  related to the mass of the atria; therefore, the larger 
the dog, the greater the predisposition to develop AF (5). 
Dogs with AF may exhibit a wide range of clinical signs, depending on the 
presence and severity of underlying heart disease. They may present with clinical signs 
consistent with heart failure, such as cough, dyspnea, ascites, weak pulse, exercise 
intolerance, weakness, lethargy, inappetance and syncope (4). Sometimes AF is an  
___________ 
This thesis follows the style of CanadianJournal of Veterinary Research. 
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incidental finding without any cardiovascular clinical sings.  
The main goal of therapy in canine patients with AF is to optimize heart rate 
(HR) and if possible convert, restore, and maintain sinus rhythm (6).  Heart rate control 
is typically achieved with antiarrhythmic medications.  The rationale for considering rate 
control as a treatment option is that hemodynamic impairment caused by the rapid rate 
often associated with AF may be partially or totally reversed with effective heart rate 
control, depending on the underlying disease (7). However, in  veterinary practice 
evaluation of HR may be problematic because routine procedures for  HR determination 
such as counting arterial pulses, auscultation of the heart, and an in clinic resting ECG 
may not adequately predict whether the AF ventricular rate response is well controlled 
with the selected antiarrhythmic therapy when an animal is stressed in the hospital 
environment.   
In healthy adult dogs, the normal HR may vary between 30 and 200 beats per 
minute (bpm), primarily as a result of integration of fluctuating autonomic influences on 
the sinoatrial node (sympathetic stimulation increases the HR, whereas parasympathetic 
stimulation decreases the HR) (8) and due to many additional factors such as breed, age, 
physical activity, respiration, thermoregulation, and stress or anxiety (9). The HR in 
dogs with AF is difficult to monitor and evaluate clinically, because it is irregular and 
usually very fast. 
There are many techniques used to evaluate or measure HR. The methods most 
commonly used in the hospital setting are palpation of arterial pulse, heart auscultation, 
and resting surface ECG. Each of these methods has specific limitations including stress 
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to the patient caused by the examination and the short period of time the parameter is 
assessed (for example a 1 to 2 minute ECG). For these reasons, HR can be difficult to 
accurately assess and therefore can make it challenging to select appropriate therapy and, 
determine effectiveness of therapy.  (10). 
When palpation of an arterial pulse is performed for evaluation of HR in a dog no 
equipment is needed, which makes it a fast and inexpensive diagnostic tool.  The 
potential inaccuracies in HR estimation are related to two factors.  First, the HR is 
typically rapid and the rhythm is irregular in AF, making it difficult to count. Second, 
pulse deficits are common in dogs with AF due to the rapid HR and rhythm irregularity 
related to variation in ventricular filling times and pulse strength, which frequently leads 
to underestimation of true HR. In addition, stress in the hospital environment may cause 
an increase in sympathetic tone contributing to an elevation in HR.  
Auscultation is a readily available, inexpensive, fast, and practical way of 
assessing HR. It can be performed by anyone trained to use a stethoscope. However, this 
technique too is susceptible to inaccuracies and therefore not always reproducible, 
because of external noise, patient motion, loud respiratory noise or panting and evaluator 
inexperience. Auscultation is particularly difficult when the HR is fast and irregular, 
which is frequently the case in AF (11). Finally, auscultation is carried out in the hospital 
and thus subject to the above mentioned  limitations with respect to environmental 
stress. 
The resting surface ECG is considered to be the best method for measurement of 
HR (12). It is a useful and non-invasive technique that provides critical information 
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regarding the electrophysiological function of the heart that cannot be assessed by other 
conventional methods (13). However, it may also have limited value because it is 
typically used only to record a brief period of heart rhythm (1 to 2 minutes, which would 
only represent 0.07-0.14% of all cardiac depolarizations that occur during a 24-hour 
period). Furthermore, the resting ECG is performed in the hospital requiring that the dog 
be restrained in right lateral recumbency with electrodes attached to the skin typically by 
some form of  clips (12) which may cause increased stress, potentially increasing the 
HR, and making it even more difficult to obtain a reliable or representative HR.  
Holter recordings (continuous, 24-hour ambulatory ECG monitoring) represent a 
way of circumventing many of the limitations in determining average resting HR in dogs 
with AF that were outlined in previous methods (14, 15) Holter monitoring involves 
placing a noninvasive medical device with the help of a vest and tape on the dog for an 
extended period, typically 24 hours, while the dog is allowed to return to his or her 
normal activity at home. These devices are typically used to diagnose or better define the 
clinical significance of abnormal heart rhythms, but using them to solely estimate the 
HR has rarely been reported to assess dogs with AF. One recent study by Colland et al 
reported that Holter monitor testing showed significantly lower HR values than in-clinic 
ECG for dogs with clinically unstable AF (16). The goals of Holter monitoring  in dogs 
with AF is to accurately determine the average daily HR (17), and correlate clinical signs 
with the presence, severity, and frequency of other cardiac arrhythmias in the dog’s 
home or natural environment during the course of normal activities for an extended 
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duration (9). The expectation is that this will yield more representative and accurate 
information and result in improved clinical outcome (18).  
Even though the clinical utility of Holter monitoring is well established, its 
clinical application has some practical limitations.  Disadvantages include availability, 
relatively high client cost, the need for special software, delay in analysis, and the 
necessity of having trained personal to read and manage the data collection (18, 19). 
Another limitation is that dogs have to be constantly supervised by their owners during 
the recording period to avoid chewing or detachment of the device.  
The data obtained by this method is of critical relevance to the veterinarian, since 
medical and therapeutic approaches selected for a dog suffering from AF are dependent 
on these data (2). In 2004, Gelzer et al demonstrated that in hospital ECG poorly 
represented average HR in dogs with AF when compared to a 24 hour Holter recording 
from a home environment leading this study to conclude that 24hr Holter monitoring is 
more accurate (20). 
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2. MATERIALS AND METHODS 
 
2.1 Dog selection  
Seven client-owned dogs previously diagnosed with clinically stable AF were 
selected from the caseload of the cardiology service at the Small Animal Veterinary 
Teaching Hospital at Texas A&M University from September, 2006 to May, 2007. 
Enrollment criteria included the diagnosis of AF that was well controlled by medication. 
Patients were considered well controlled if no changes in cardiac medications were 
required on the day of evaluation or during the Holter recording. The sex, age, breed, 
weight and underlying diagnosis were obtained from the medical record of each dog. An 
owner consent form was signed by the person responsible for each animal. 
 
2.2 Heart rate monitoring 
On the day of enrollment, a complete history was taken and a physical 
examination was performed by an ACVIM board-certified cardiologist or cardiology 
resident. Next, a six-lead resting surface ECG was performed on each dog (see Appendix 
A). The ECG was recorded with the dog gently restrained in right lateral recumbency. 
Alcohol was applied to the areas of electrode attachment, electrode clips were applied to 
the dog’s limbs and then the ECG recording started. The ECG was recorded for 60-180 
seconds. Once the recording was complete, the clips were removed and the ECG was 
evaluated and saved in the patient file.  
 For the entire ECG recording period, minimum, maximum, and average HR were 
calculated manually by the author under a specialist’s supervision. The method used to 
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calculate minimum ECG HR was determined by selection of the longest R-R interval 
which was then converted to HR using the formula; 60 sec / R-R interval (sec) . 
Maximum HR was determined by  selection of the shortest R-R interval and converted 
to HR using the formula listed above. Finally, ECG average HR was calculated by 
counting the number of R-R intervals in a representative 6 second interval and 
multiplying by 10 (paper speed was 25 mm/sec).   
 Immediately after the ECG, a Holter monitor was placed according to the 
Reynolds Lifecard system Holter hook-up procedure (Appendix B).  Dogs were allowed 
to return home, and owners were encouraged to continue their normal daily routine and 
to maintain a diary of medication, sleep, exercise, and other activities thereby allowing 
evaluation and correlation of the variations in HR based on the animal’s behavior.  
 After 24-hours, the owners were asked to remove the monitors from their dogs 
and return them by overnight courier to the Texas A&M Small Animal Medical 
Teaching Hospital. When the device was received, the data from the Holter Lifecard was 
downloaded and analyzed using Del Mar Reynolds software (Impresario ®).  
The recording memory of the Holter monitor was digitized and analyzed by 
personnel trained in the use of the analysis software. This is a prospective analysis 
software system that shows every ventricular depolarization (QRS) recorded during the 
time the device was connected to the dog. Because the HR is typically very fast and 
irregular with AF, the operator must manually confirm the software’s identification of 
each QRS complex.  Accurate identification of each QRS complex is necessary for the 
software program to  provide an accurate summary showing the total number of QRS 
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complexes during the recording period of time, the maximum, minimum, and average 
HR per hour as well as the number of abnormal beats, with the exact times of their 
occurrence and length or any paroxysms or pauses.  
During manual scanning of the recording numerous artifacts were identified. The 
rapidity and irregularity of the rhythm resulted in many QRS complexes that were not 
identified by the software. Therefore, the operator had to manually scan the entire 
recording for accuracy and identify all QRS complexes that were not identified by the 
software program in order to assure accurate summaries by the software program. When 
a question or doubt arose, the cardiologist was contacted to review the report provided 
by the software program.  
Summary information was generated by the software program as outlined below.  
 1. Determination of overall minimum HR. The minimum HR was determined 
from a 60 second interval. The interval was selected by the software program. The 
program determined the HR for the initial 60 seconds of the recording and then 
determined the HR from interval 2 (01 second to 61 seconds) then interval 3 (02 -62 
seconds) and so on through the entirety of the recording (rolling 60sec average). The 
minimum HR was then selected from all available 60 second intervals.   
  2. Determination of overall maximum HR. The maximum HR was determined 
from a 60 second interval. The interval was selected by the software program. The 
program determined the HR for the initial 60 seconds (0-60 seconds) of the recording, 
then determined the HR from interval 2 (01 second to 61 seconds) and then interval 3 
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(02 -62 seconds) and so on through the entirety of the recording (rolling 60 sec average). 
The maximum HR was then selected from all available 60 second intervals.   
3. Determination of overall average HR. The average HR was determined 
from the average of all 60 second intervals. The program determined individual 60 sec 
interval HR as follows: HR for the initial 60 seconds (0-60 seconds) of the recording, 
then determined the HR from interval 2 (01 second to 61 seconds) and then interval 3 
(02 -62 seconds) and so on through the entirety of the recording. 
4. Hourly Holter HR parameters were determined as outlined above for overall 
Holter HR parameters but instead of evaluating the entire recording the Holter was 
analyzed in 1 hour intervals.  
 
2.3 Statistical analysis 
 Numeric variables were described by mean, standard deviation, and range.  
Holter and ECG average, minimum and maximum HRs were compared using t-tests for 
each dog who had both Holter and ECG data available.  To compare the differences 
between Holter and ECG average, minimum and maximum HRs, a linear regression 
model with a random effect for each dog was used. All analyses were performed using 
Stata® version 10.1 software. 
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3. RESULTS 
 
3.1 Descriptive statistics 
The mean age and body weight of all dogs was 6.78 years (Range 3.0 –13.0) and 
48.3 kg (Range 23.0-73.5), respectively. There were five males and two females of the 
following breeds: Great Dane (3), Rottweiler (2), Poodle (1), and mixed (1) (Table 1). 
 
Table 1. Dog demographics 
 
* a) Amiodarone, b) Aspirin, c) Atenelol, d) Benazepril, e) Cephalixin, f) Dilacor, g) and 
h) digoxin i) Doxycycline, j) Diltiazem, k) Enalapril, l) Famotidine, m) Furosemide, n) 
Levothyroxine, o) Metronidazole, p) Pimobendan, q) Prednisone, r) Spironolactone, s) 
Sildenafil, t) Sucralfate. 
 
Dog 
# 
Gende
r 
Age 
(years) 
Weight 
(kg) 
Breed 
Underlying 
diagnosis 
Current 
medication* 
 
 
 
 
 
 
 
 
   
1 Male 5.0 73.5 Great Dane ODCM, MR, VPCs d    
2 Male 6.0 47.5 Rottweiler DCM, CHF, BE d,r,m,p,a,f    
3 
Femal
e 
6.0 39.3 Rottweiler 
SAS, CHF, 
Hypothyroidism 
d,m,p,a,n,l,g,j,q,
t,o 
   
4 
Femal
e 
11.0 28.0 Poodle DVD, CHF, PH,  
k,m,r,p,c,s,h,b,i    
5 Male 13.0 23.0 Mixed DVD, PH k,m,r,p,c,s,h,b,i    
6 Male 3.0 58.90 Great Dane TVD p j,d,g    
7 Male 3.5 68.18 Great Dane ODCM, LD d,a,e    
 Mean 6.78 48.34     
 
Stand. 
dev. 
3.78 19.48 
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The surface ECGs were read and interpreted in 5 dogs, giving three separate 
measures of heart rate. The average duration of the surface ECG was 100.8 seconds with 
a range of 81.0 to 126.0 seconds (Table 2). 
 
Table 2. ECG duration 
 
 
The mean minimum HR of all dogs was 85 bpm and the mean maximum HR was 194 
bpm. The mean average HR for all dogs was 124 bpm (Table 3). 
 
Table 3. ECG heart rate  
Dog # ECG minimum ECG average ECG maximum 
1 81 132 214 
2 100 121 167 
3 69 95 188 
4 -- -- -- 
5 -- -- -- 
6 48 115 188 
7 103 150 214 
Mean 80.20 122.6 194.20 
Stand.dev. 22.77 20.38 20.00 
 
 
Dog # ECG duration (sec) 
1 108 
2 81  
3 84 
4 No ECG available 
5     No ECG available 
6 126 
7 105 
Mean 100.8 
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Holter recording HR was reported as three separate measures: 
The mean minimum Holter HR for all hourly readings for all six dogs was 100 
bpm (Range 61-155). The mean maximum HR for all hourly readings for all six dogs 
was148 bpm (Range 90-212), and the mean average HR for all hourly readings for all 
six dogs was 118 bpm (Range 79-170) (Table 4). 
 
Table 4. Holter heart rate 
Dog # Holter minimum Holter average Holter maximum 
1 -- -- -- 
2 102 151 200 
3 73 157 212 
4 76 155 208 
5 69 164 173 
6 61 83 189 
7 146 156 167 
Mean 87.83 144.33 191.5 
Stand. dev. 31.68 30.34 18.51 
 
 
Figures 1 through 4 show the minimum, average, and maximum HR data collected on 
the four dogs in which both Holter and ECG data were available, by time, in hours. 
Circular markers observed are Holter HRs. Straight solid lines are mean Holter 
minimum (green), mean Holter maximum (red) and the mean Holter average (blue). 
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Figure 1. Dog # 2 ECG and hourly HR 
 
 
 
Figure 2. Dog # 3 ECG and hourly HR 
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Figure 3. Dog # 6 ECG and hourly HR 
 
 
 
Figure 4. Dog # 7 ECG and hourly HR 
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3.2  Statistical analysis 
The comparison analyses were only carried out on the five dogs that had both 
Holter and ECG data available. The dogs’ HRs were analyzed individually using a one-
sample t-test to compare Holter HRs to the ECG HR. Three variables for both ECG and 
Holter were used, giving a total of nine possible different comparisons per dog (see 
Table 5).  
 
Table 5. Summary of the p values from t-tests comparing Holter to ECG by dog. 
Comparison Dog #2 Dog #3 Dog #6 Dog #7 
N (# Holter obs) 26 24 11 7 
Holter ECG p value p value p value p value 
min min 0.00 0.00 0.00 0.00 
min avg 0.11 0.00 0.00 0.36 
min max 0.00 0.00 0.00 0.00 
avg min 0.00 0.06 0.27 0.00 
avg avg 0.00 0.00 0.02 0.00 
avg max 0,00 0.00 0.00 0.00 
max min 0.00 0.00 0.00 0.00 
max avg 0.00 0.00 0.00 0.01 
max max 0.36 0.00 0.00 0.00 
 
 There are significant differences for at least one dog for each comparison. The 
only comparisons showing any lack of significance (that is, at least one comparison with 
a large p-value) are    
 Holter minimum compared to ECG average,   
 Holter average compared to ECG minimum, 
 Holter maximum with ECG maximum. 
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To compare Holter and ECG HRs for all 4 dogs together, a linear regression model 
with a random effect for each dog was used, with the response variable being the 
difference between a Holter HR and an ECG HR (ECG-Holter). The results are listed in 
Table 6 and estimated differences are displayed graphically in Figure 5, together with 
95% confidence intervals. 
 
 
 Table 6. Summary of the p values, sample size N and estimated difference from linear 
regression comparing Holter to ECG (ECG-Holter). 
 Holter minimum Holter average Holter maximum 
 p N ECG-H p N ECG-H p N ECG-H 
ECG min 0.06 64 -23 0.00 64 -40 0.00 64 -71 
ECG avg 0.74 64 4 0.22 64 -13 0.00 64 -45 
ECG max 0.00 64 79 0.00 64 63 0.00 64 31 
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Figure 5. Estimated average difference between Holter and ECG HRs (ECG-Holter), 
with 95% confidence interval. 
 
This analysis shows that the difference between the Holter average HR and the 
ECG average HR are not statistically significantly. The difference between Holter 
minimum and ECG average was not significant at the 5% level, and the estimated 
average difference between them is only 4 beats-per-minute. The estimated average 
difference between average ECG and average Holter HR is 13  beats-per-minute.  
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4. DISCUSSION 
 
Atrial fibrillation is one of the most common arrhythmias that requires treatment 
in veterinary medicine (21). The treatment goal in dogs with this arrhythmia is typically 
to optimize HR (22). Many studies have reported the use of Holter recordings and the 
surface ECG in dogs with cardiac diseases, but at the time this study was initiated there 
were no prior publications of the comparison of these two methods for evaluating HR in 
dogs affected with spontaneous AF. This study suggests that there is not a significant 
difference between the average HR calculated by these two methods in clinically stable 
spontaneous AF.  However, recent abstracts and convention proceedings have reported 
that average HR determined by Holter is lower than those determined from ECG and is 
thus more accurate. (16, 20)  However, these patient populations were not well described 
do to the limited nature of abstract publications and may not represent the same 
population of dogs reported in this study which could explain the apparent discrepancy.  
Studies that compared Holter and ECG for evaluation of HR in dogs with sinus 
rhythm reported that the average HR from the surface ECG consistently exceeded the 
average Holter heart rate (15). Another previous veterinary study by Gelzer et al 
suggested ECG is not an accurate technique to estimate HR in dogs with AF (23). 
      Potential limitations of this study include the following:  
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4.1 Sample population  
            The dogs for this study were not a homogeneous sample, the only inclusion criterion 
was a previously diagnosed AF that is stable and not in need of adjustments of cardiac 
medications on the day of the evaluation or while wearing the Holter. But prior studies 
in dogs have evaluated the influence of sex, age, heart rate, and body position during  
ECG, and they showed by statistical analysis that there was not a physiological 
difference observed in the minimum, median, and maximum cardiac rates (13, 15). 
Nevertheless, the sample, composed of four animals, is by no means representative of all 
dogs affected with AF.  
 
4.2 Client and owner 
            The device requires constant owner attention  to avoid detachment of the device from  
the dog. Even though clients were encouraged to follow normal  daily activities at the time 
of ambulatory ECG recording, many of them reported in the diaries they kept that 
excessive attention was given to the dog and thus it avoided its normal behavior. Anxiety 
or stress from having the Holter monitor attached could also affect the HR and lead to 
overestimation of the HR. 
           Although the Holter technique does not imply any risk to the animal, some discomfort 
may be provoked, which would result in the removal of the device, giving at the time of 
reading many artifacts or loss of data. So as not to cause irritation or alert, owners must 
be prompted to the fact that when the electrodes are removed a mild erythema will 
sometimes be present at the site of detachment. 
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4.3 Holter device and software  
Because the software used to read the Lifecard of Holter was designed for 
cardiac evaluation in humans, interpretation errors are possible when it is used on 
veterinary patients. For example, in dogs, the average normal HR is higher than in 
humans, and in dogs with AF it is even higher, therefore missing data by the program 
has a high probability of occurring. Our goal was to have a 24-hour Holter recording and 
an ECG for each dog, but the Holter reading was not clear or readable for this period in 
all cases.  
In addition, the limitations of this Holter software made the analysis of each 
recording labor-intensive since each missed beat had to be manually confirmed by the 
operator. Some of the dog Holter analysis readings took 3 hours, whereas some took up 
to a week to review. 
It is almost certain that the limitations mentioned above will be overcome with 
time and fine-tuning of technology for evaluation of canine studies in such a way that 
this method will be applied with the same frequency and accuracy that has been 
accomplished in the field of human medicine. In addition, it will be necessary to specify 
optimal parameters and conditions for evaluation, to decrease the Holter recording time 
and specify during which dog’s activities. Finally, it will also be very important to 
determine the situations in which the use of the Holter method is strictly necessary so as 
to promote the diagnosis of cardiac alterations and improve its use in therapeutic studies. 
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5. CONCLUSIONS 
 
The results of this study show that there was no significant difference when 
comparing the average Holter HR versus average ECG heart rate in dogs with clinically 
stable spontaneous AF in 4 dogs. The importance and clinical relevance of this 
conclusion is that surface ECG HR recorded at the hospital appears to be as reliable as 
when a Holter device is applied for hours in dogs with stable spontaneous AF. 
Despite the results, the limitations of this study regarding the number of dogs and 
the software must be noted. It is highly probable that the accuracy of the Holter software 
analysis will be improved for its use in small animals. And when this occurs, more 
studies regarding AF or other kinds of disturbances in cardiac electrical activity and its 
monitoring will be better understood, and more important they will be controlled giving 
to the dogs affected a better quality of life, as well as for their owners. 
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APPENDIX A 
 
  
ECG monitoring  
1. The ECG was recorded with the dog lying on its right side. No sedation or anesthesia 
was used in the dogs for this study in order to avoid any drug influence on the heart. 
2. Conductive gel was applied to the skin of the dog for a better transmission of the 
electrical activity of the heart to the ECG machine. 
3. The electrodes were attached to the chest wall, and after that to the lead cables that 
were connected to the ECG machine. 
4. The activity generated by the heart was recorded for 3 min. 
5. Once the recording was completed, the clips were removed. 
6. ECG data were evaluated with the help of a cardiology specialist at the Texas A&M 
Small Animal Hospital.  
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APPENDIX B 
 
Holter placing and monitoring 
1. The hair-coat was shaved over the area where the heartbeat is palpated for a better 
contact of the skin. 
2. At that site, the skin was cleaned and degreased using alcohol and allowed to dry 
completely. 
3. Using an ECG self-adhesive electrode, the red electrode was placed on the left side of 
the chest and attached over the left apex beat.  
4. With the help of a second adhesive electrode placed on the left side of the chest 
(slightly higher up the rib space and 1–2 rib spaces further forward than electrode 1) the 
yellow electrode was attached. 
5. A third electrode was positioned on the right side of the chest, where the heartbeat 
was feeling best. The green electrode was attached to this area. (Figure 1) 
6. A bandage was used over the electrodes and the leads, once around the chest to ensure 
there was no interference or movement of these electrodes. Making sure that the dog was 
not bandaged too tightly or heavily, a specially designed jacket was then used to affix 
the Holter recorder to the dog. 
7. After assuring that the Holter was secure and the dog the most comfortable possible, 
the recording of the Holter was started.  
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Figure 6. Diagram showing the correct sites of holter electrode application in a dog. 
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APPENDIX C 
 
ECG equipment 
General Electric 
GE Marquette 
MAC 5000 
Milwake, USA 
 
Holter equipment 
LifecardCF Delmar Reynolds, USA 
 
Software equipment  
Delmar Reynolds software (Impressario ®), USA. 
 
Statistical analysis software 
Stata® version 10.1  
StataCorp LP,  
4905 Lakeway Drive,  
College Station Texas 77845 
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